Platelet transfusion for severe brain injury on blood thinners
Part of Brain & nervous system, Heart & circulation, Injuries & trauma clinical trials.
This trial tests whether giving a platelet transfusion to patients with severe traumatic brain injury who are on antiplatelet medication can improve how well their blood clots. You may qualify if you have a serious brain bleed and are taking a medication like aspirin or clopidogrel.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a traumatic brain injury with bleeding that is classified as moderate to severe.
- You are currently taking an antiplatelet medication (like aspirin or clopidogrel) and took it within the last 48 hours.
- You are not taking a blood thinner for clots in your legs or heart (like warfarin or apixaban).
- You do not have other serious injuries like broken bones or damage to your internal organs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a clot-busting drug called tenecteplase to see if it can safely treat a large brain bleed (intracerebral hemorrhage). It may help people who had a bleed within the last 24 hours and whose CT scans show the bleed has stopped growing.
This trial tests whether taking an anti–blood clot medicine (dalteparin) and using leg compression can reduce dangerous blood clots after a severe traumatic brain injury. It may help lower the chance of clots forming when people are immobile and at higher risk.
This trial tests whether a common antiplatelet medicine can reduce the risk of future heart attacks, strokes, or blood clots in people who have had a brain bleed. It's for adults who had their first brain bleed and can start treatment within 3 months of the stroke.
This study looks at how inflammation and changes in the blood-brain barrier occur after a spontaneous brain bleed. Researchers use special brain imaging and scans to understand these processes, which may help improve treatment in the future.
This trial tests whether a special blood clotting test called thromboelastography can help assess clotting problems after a head injury. It may help doctors better understand bleeding risk and related complications early after trauma.
This clinical trial tests whether a medication called cilostazol can help the body reabsorb a brain bleed (intracerebral hemorrhage) more quickly. It is for adults with a small bleed in a specific part of the brain (thalamus or basal ganglia) who are otherwise in good health.
Hear when a new Traumatic Intracranial Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.